Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • EOG vs GSK✓SelectedUSD · GSKEOG vs GSK performance historyLatest closeAs of-1.80%11/16
Stock and ETF performance explorer

EOG vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+8,209.7%
GSK return
+1,741.1%
Excess return
+6,468.6%
Maximum drawdown
-77.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.8%-0.1%-1.7%-1.8%
7D+4.7%-1.3%+6.1%+5.1%
30D-1.6%+2.7%-4.3%-2.5%
3M+9.8%+2.7%+7.0%+8.6%
6M+12.4%+3.3%+9.1%+10.7%
YTD+52.8%+6.5%+46.3%+48.3%
1Y+45.3%+10.7%+34.6%+39.5%
3Y+43.3%+64.4%-21.0%+20.8%
5Y+114.7%+46.7%+68.0%+84.5%
10Y+126.6%+109.4%+17.3%+75.4%
All+8,209.7%+1,741.1%+6,468.6%+4,919.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling